Northwest & Ethical Investments L.P. Profound Medical Corp. Transaction History
Northwest & Ethical Investments L.P.
- $3.68 Trillion
- Q4 2024
A detailed history of Northwest & Ethical Investments L.P. transactions in Profound Medical Corp. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 46,200 shares of PROF stock, worth $345,576. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,200
Previous 23,700
94.94%
Holding current value
$345,576
Previous $189 Million
83.75%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PROF
# of Institutions
56Shares Held
13.6MCall Options Held
3.9KPut Options Held
1.4K-
Fil LTD Hamilton, D01.8MShares$13.4 Million0.01% of portfolio
-
Gagnon Securities LLC1.65MShares$12.4 Million2.68% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.21MShares$9.06 Million0.18% of portfolio
-
Timelo Investment Management Inc.912KShares$6.82 Million4.82% of portfolio
-
Gagnon Advisors, LLC897KShares$6.71 Million4.87% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $156M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...